RSM logo
Laboratory Animals

Home Current issue Browse archive Alerts About the journal Feedback
 
This version was published on 1 October 2008
Lab Anim 2008;42:453-464
doi:10.1258/la.2007.007001
© 2008 Laboratory Animals Limited

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
la.2007.007001v1
42/4/453    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egermann, M
Right arrow Articles by Lill, C A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers

A sheep model for fracture treatment in osteoporosis: benefits of the model versus animal welfare

M Egermann * {dagger} , J Goldhahn {ddagger}, R Holz *, E Schneider * and C A Lill {dagger}

* AO Research Institute, Clavadelerstrasse, CH-7270 Davos Platz, Switzerland; {dagger} Department of Orthopaedic Surgery, University of Heidelberg, Heidelberg, Germany; {ddagger} Schulthess Clinic Zürich, Zürich, Switzerland

Correspondence: M Egermann. Email: marcus.egermann{at}aofoundation.org

Animal models are necessary to evaluate new options for the treatment of fractures in osteoporotic bone. They permit both the biological response of a living system and the influence of the pathological processes to be taken into account. A sheep model for osteoporosis was established by combining oestrogen deficiency, calcium and vitamin D-deficient diet with steroid medication. Bone mineral density (BMD) was reduced by >30% after 12 weeks of combined treatment. Osteoporosis similar to the human situation with corresponding changes in the micro-architecture and mechanical properties of bone was observed. This publication focuses on the impressive results obtained with the model and contrasts them with considerations of animal welfare. Considerable side-effects associated with steroid medication became manifest. Animals in the treatment groups showed signs of infection of various degrees due to the immunosuppressive effect of the medication. The infections were mostly caused by Corynebacterium pseudotuberculosis. Antibody testing revealed a 100% prevalence of infection in this breed of sheep. A modification of the steroid treatment, i.e. less-frequent injections, reduced the incidence of side-effects. This sheep model shows a significant and reproducible reduction in cancellous BMD of >30%, including relevant changes in biomechanical properties and increased fracture risk. However, the severity of the side-effects cannot be overlooked. The model must be improved if it is to be used in the future. Options to reduce the side-effects are discussed.

Key Words: Animal model • osteoporosis • bone • sheep • fracture


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




How Not to be a Doctor